Mayo seminars in psychiatry: Dopamine and schizophrenia - a review

P. Fredrickson, E. Richelson

Research output: Contribution to journalReview articlepeer-review

4 Scopus citations

Abstract

Considerable evidence exists linking dopamine with schizophrenia. Other neurotransmitters including acetylcholine, serotonin and gamma-aminobutyric acid (GABA) are also being implicated. Neurotransmitters act via receptors on brain cells and evidence suggests that antipsychotic drugs exert their therapeutic actions and produce side effects by receptor blockade.

Original languageEnglish (US)
Pages (from-to)399-405
Number of pages7
JournalJournal of Clinical Psychiatry
Volume40
Issue number9
StatePublished - 1979

ASJC Scopus subject areas

  • Psychiatry and Mental health

Fingerprint

Dive into the research topics of 'Mayo seminars in psychiatry: Dopamine and schizophrenia - a review'. Together they form a unique fingerprint.

Cite this